Clinical Trial

Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye Disease

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2024 (before its estimated October 1, 2024 completion). Its status may not reflect the trial's current state.
Summary
Objective: To evaluate the effect of transcutaneous auricular vagus nerve stimulation (taVNS) for the patients with dry eye disease with meibomian gland dysfunction. Methods: We enrolled 256 patients at Beijing Tongren Hospital. Patients completed questionnaires at baseline, 1 month, 3 months, and 6 months.OSDI score, TBUT, Schirmer I, tCFS, MGD score, and psychological status to evaluate the therapeutic effects. A difference of P \< 0.05 was considered statistically significant.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-12-16; most recent amendment 2024-09-15.
Status change: Completed → Recruiting 2024-09-15
Trial Details
NCT Number NCT04673643
Lead Sponsor Beijing Tongren Hospital
Conditions Dry Eye Disease
Enrollment 128 participants
Start Date 2021-07-01
Primary Completion 2024-10-01 (estimated)
Study Completion 2024-10-20 (estimated)
Updated on ClinicalTrials.gov 2024-09-19